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Contrast echocardiography in
daily clinical practice
Despite technological advances in echo-
cardiography, such as harmonic imag-
ing, a signiﬁcant number of rest or stress
echocardiography studies are labeled as
nondiagnostic. Even in the presence of
adequate image quality, some cardiac
structural abnormalities pose a diagnos-
tic challenge. Ultrasound contrast agents
(UCAs) have been shown to improve
the diagnostic accuracy of echocardiog-
raphy. Furthermore, assessment of my-
ocardial perfusion by means of contrast
echocardiography has been extensively
studied with proven independent di-
agnostic and prognostic beneﬁts. This
paper (a) brieﬂy highlights some tech-
nical aspects of UCAs and the relevant
imaging techniques and (b) summarizes
the use of contrast echocardiography in
daily clinical practice.
Ultrasound contrast agents
Use of UCAs in echocardiography is
not new. In 1968, Gramiac and Shah
noted a cloud of echo at the tip of
cardiac catheters while doing M-mode
studies on the aortic root in the cardiac
catheterization laboratory [1]. Injection
of agitated saline for identifying right-
to-left intracardiac shunts or pulmonary
arteriovenous malformation continues
to remain a valuable clinical tool in daily
practice. Air microbubbles that act as
the contrast agent are approximately the
same size as red blood cells with strong
backscatter; however, they dissolve in
blood quickly and therefore do not
normally reach the left heart. Despite
knowing for many years that mixing
a small amount of blood with agitated
saline increases microbubble stability (as
blood surfactant forms a protective shell
around the microbubble), it was only
in early 1990s that commercial UCAs
became available [2]. Thus, in order
to overcome the instability of contrast
microbubbles in blood, they should be
either protected with a shell or should
contain a gas that is insoluble in the blood
so that they can reach the left ventricular
cavity and the myocardium. The ﬁrst
generation of UCAs had air or nitro-
gen microbubbles protected by a thick
shell (such as albumin). The second
generation of UCAs instead has high-
molecular-weight gases that are insoluble
in blood. UCAs should also ideally have
distinct acoustic properties to provide
eﬃcient backscatter, have a similar size
to red cells in the blood, and circula-
tion and must survive the pulmonary
passage without aggregation. The most
important factor in the echogenicity of
the UCAs is their size, and therefore the
biggest possible size of a UCA that is
able to cross the lungs will produce the
highest ultrasound backscatter. . Table 1
summarizes some of the commercially
available UCAs. Unlike red cells that
only become echogenic in aggregation
and slow blood ﬂow state, UCAs pro-
duce ultrasound backscatter even in
normal blood ﬂow that is typically up
to 100 million times stronger than red
cells.
The acoustic behavior of UCAs in re-
sponse to the diﬀerent range in ultra-
sound mechanical index (MI) is an im-
portant part of contrast echocardiogra-
phy. MI is directly proportional to an
ultrasound beam’s peak negative pres-
sure and inversely proportional to the
frequency of the beam and is considered
as the ultrasound acoustic power. In an
MI > 0.1, contrast microbubbles con-
tract andexpandunequally, whichmeans
they will produce ultrasound backscatter
witha loweramplitude than the transmit-
ted fundamental frequency, the so-called
nonlinear response. In lowerMImyocar-
dial tissue backscatter, however, typically
shows a linear response, i. e., producing
backscatter signals at the sameamplitude.
Modern scanners will be able to cancel
out the tissue backscatter and image only
reﬂected signals from the UCA. An MI
of more than 0.9 will cause destruction
of the UCA resulting in brief but strong
nonlinear backscatter signals that also
can be used in contrast echocardiogra-
phy. In summary, the two techniques are
called low-MI and high-MI imaging, re-
spectively. The real-time low-MI (<0.3)
techniques are those that are more rou-
tinely used in clinical practice [3].
Clinical utility of contrast
echocardiography
Contrast echocardiography is used for
a variety of diagnostic and prognostic
reasons. . Table 2 summarizes the clin-
ical indications of contrast echocardio-




Assessment of global and regional left
ventricular function has both diagnostic
and prognostic value in a range of car-
diac conditions such as coronary artery
disease, heart failure, and cardio-oncol-
ogy. It is well reported that up to 15%
of echocardiography studies are unin-
terpretable owing to poor image quality.
This is even more prominent in critically
ill patients and has been reported to be
as high as 30% [4]. Both American and
European guidelines advocate the use of
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Table 2 Clinical indications for contrast echocardiography
1. Quantiﬁcation of left ventricular (LV) volumes and LV ejection fraction, assessment of regional
wall motion abnormality at rest
– Improvement in endocardial border delineation in diﬃcult-to-image patients
– To increase accuracy and reproducibility in all patients
– To increase reader conﬁdence in all patients
2. LV structure abnormalities
– Apical LV thrombus
– Apical hypertrophic cardiomyopathy
– LV Non-compaction
– LV rupture, aneurysm, and pseudo-aneurysm
2. Cardiac masses, thrombus
3. Improvement in right ventricle visualization and great vessels
3. Enhancement of Doppler signals for evaluation of valvular disease/diastolic function
4. Stress echocardiography
5. Perfusion imagingwith myocardial contrast echocardiography
UCAs to improve endocardial border de-
lineation when two or more segments of
the left ventricle cannot be well deﬁned
[5, 6]. The salvage of such nondiagnos-
tic studiesusing leftventricularopaciﬁca-
tion(LVO)hasbeenreportedtobeashigh
as approximately 50%withhigher rates of
salvage in the intensive care unit [7–9].
It is only with the advent of contrast
echocardiography that the percentage of
nondiagnostic echocardiography studies
has dropped to less than 5% [4]. More-
over, quantiﬁcation of ejection fraction is
imperative in daily practice both in clin-
ical decision-making, e.g., eligibility for
device therapy with an ejection fraction
<35%, and in serial studies such as mon-
itoring of the left ventricular function
in valvular heart disease. Measurement
of ejection fraction by unenhanced two-
dimensional (2D) echocardiography has
inherent limitations resulting in under-
estimation by up to 6% and a signiﬁcant
variability of up to 14% [10, 11]. Several
studies have shown that LVO improves
the accuracy of ejection fraction mea-
surements and reproducibility [6] and is
recommended in relevant clinical indi-
cations. UCAs have also been used with
three-dimensional (3D) echocardiogra-
phy. Recent studies have shown that 3D
contrast echocardiography provides the
closest results to cardiac magnetic reso-
nance in measuring left ventricular vol-
umes. It further reduces variability and
improves accuracy of left ventricle vol-
umemeasurementswhencomparedwith
2D contrast echocardiography [12, 13].
Image Optimization. Conventional 2D
echocardiography uses high MI that re-
sults indestructionofcontrastmicrobub-
bles. When performing an LVO study,
this will result in contrast swirling, espe-
cially in the apical area that is closer to the
ultrasound beam source. Furthermore,
at high MI, tissue will also produce har-
monic backscatters (nonlinear response)
that make delineation of the endocardial
border more diﬃcult. For these reasons,
LVO studies should be performed with
low MI (<0.3), which is usually available
on modern echocardiography machines,
to reduce microbubble destruction and
tissue signals. The focal zone should be
at the level of the mitral valve annulus
and a minimum frame rate of 25MHz is
required. Adjusting time gain compen-
sation helps to achieve a homogeneous
opaciﬁcationof the left ventricle from the
apex to thebase. Bolus injectionsareusu-
allyused forLVOstudies and shouldbeof
such volume that adequate opaciﬁcation
of the left ventricle is reached. In high
volumes of contrast, however, microbub-
bles can act as a barrier to the ultrasound
beam and cause attenuation resulting in
the far ﬁeld view being attenuated. This
can be resolved by using the “ﬂash” or
“burst” function that sends high-MI ul-
trasound beams over 4–5 frames and de-
stroys the contrast allowing for a better





a sensitivity as high as 93% for diagnos-
ing cardiac masses [14]. Left ventricular
thrombus is the most commonly diag-
nosed mass that can pose a diagnostic
challenge, especially in cases of poor
image quality or near-ﬁeld artifact. Use
of real-time low-MI LVO will help de-
lineate a mural or laminar thrombus
(. Figs. 2 and 3). Using the ﬂash option
that destroys themicrobubbles allows for
visual assessment of replenishment of the
adjacent myocardium to determine any
perfusion defects, implying a substrate
for thrombus formation. Although in the
majority of cases other diagnostic clues
will help in diﬀerentiating thrombus
from a tumor, destruction/reperfusion
techniques can be used to characterize
the mass vascularity. A thrombus will be
avascular, whereas a malignant mass or
vascularized tumor will show high vas-
cularity, and a stromal mass will present
as partially vascular.
Diagnosis of suspected apical hyper-
trophic cardiomyopathy on transthoracic
Herz
echocardiography can be conﬁrmed by
an LVO study demonstrating the spade-
shape apex with the thick apical cap
and apical systolic cavity obliteration.
Contrast LVO can also help diﬀerentiate
prominent trabecula from noncom-
paction morphology.
LVO can also be used in the detec-
tion of acute myocardial infarction com-
plications such as pseudo-aneurysm. It
has also been used with transesophageal
echocardiography to facilitate the diag-
nosis of left atrial appendage closure par-




racic echocardiography in visualization
of the endocardial border can pose an
even more signiﬁcant challenge in stress
echocardiography, when deﬁnition of
the endocardial border for detection of
regional wall motion abnormalities is
crucial. Even in cases with adequate
image quality, the respiratory eﬀort in
the case of an exercise test or tachycardia
resulting from use of inotropic agents
and the narrow window in acquiring
images could all lead to diﬃculty in
interpreting the studies. Suboptimal
studies have been reported as high as
30% in routine stress echocardiography
with an inter-institutional agreement as
low as 43% in those with poor image
quality. LVO has been shown to reduce
the nondiagnostic stress echo studies to
less than 10%, to improve test accuracy
and reader conﬁdence, and to reduce
variability in several studies [16–21].
Again, real-time low-MI imaging is
the preferred method. While bolus in-
jections are easier to adopt for exercise
stress echocardiography and should be
administered about 30 s before acquir-
ing images, an infusion can be used in
pharmacologic stress echocardiography.
Given that the infusion of the contrast
takes longer to reach the adequate con-
centration, it is best started at least 45 s
before image acquisition is performed.
As discussed, a higher concentration
of microbubbles can act as a barrier to
the ultrasound beam causing attenua-
tion. Thus stress echo imaging should
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Abstract
Ultrasound contrast agents have unique
acoustic properties that enable them to
enhance the cardiac blood ﬂow and thus are
used broadly in modern echocardiography
laboratories for salvage of nondiagnostic
studies, improving accuracy and reducing
variability even in the presence of adequate
image quality. Contrast echocardiography
is also used as an adjunctive technique
when unenhanced echocardiography
falls short in the diﬀerentiation of cardiac
structural abnormalities such as cardiac
masses. Ultrasound contrast agents are
pure intravascular tracers. Development of
innovative ultrasound imaging techniques
has led to myocardial perfusion imaging
with contrast echocardiography. Although
currently an oﬀ-label indication, it has been
shown that perfusion imaging with contrast
echocardiography adds incremental value to
stress echocardiography in the detection of
coronary artery disease. Moreover, it can be
used for assessment of myocardial viability.
In this paper we brieﬂy discuss the basics of
contrast echocardiography and its use in daily
clinical practice.
Keywords
Perfusion imaging · Ultrasonography ·
Contrast media · Coronary artery disease · Left
ventricle
Kontrastechokardiographie in der klinischen Praxis
Zusammenfassung
Ultraschallkontrastmittelweisen besondere
akustische Eigenschaften auf, durch die der
kardiale Blutﬂuss verstärkt dargestellt wird.
Daher ist ihre Anwendung in der modernen
Echokardiographie weit verbreitet, um trotz
einer wenig aussagekräftigenUntersuchung
noch zu einem Ergebnis zu kommen, die
Genauigkeit zu erhöhen und die Variabilität
selbst bei ausreichender Bildqualität zu
senken. Die Kontrastechokardiographie
dient auch als Zusatzverfahren, wenn die
native Echokardiographie zur Diﬀerenzierung
kardialer Strukturanomalien wie kardiale
Raumforderungen nicht ausreicht. Ultraschall-
kontrastmittel sind rein intravaskuläre Tracer.
Die Entwicklung innovativer bildgebender
Verfahren hat zur Myokardperfusionsbildge-
bung mit Kontrastechokardiographie geführt.
Obwohl es sich derzeit um eine Oﬀ-Label-
Indikation handelt, weist die Perfusions-
bildgebung mit Kontrastechokardiographie
nachweislich einen zusätzlichen Nutzen zur
Stressechokardiographie bei der Erkennung
der koronaren Herzkrankheit auf. Darüber
hinaus kann das Verfahren zur Beurteilung
der Erholungsfähigkeit von kontraktionsge-
störtemMyokard eingesetzt werden. In der
vorliegenden Arbeit werden die Grundlagen
der Kontrastechokardiographie und ihre
Anwendung in der täglichen klinischen Praxis
kurz erörtert.
Schlüsselwörter
Perfusionsbildgebung · Sonographie ·
Kontrastmittel · Koronare Herzkrankheit ·
Linker Ventrikel
be started with apical views since atten-
uation from the higher concentration
of the microbubbles in the right ventri-
cle can aﬀect the image quality of the
parasternal left ventricular views.
LVO for improvement of endocar-
dial border deﬁnition both at rest and
stress along with its role in deﬁning car-
diac structural abnormalities are the li-
censed applications for the use of UCAs
and should be an integral part of any
echocardiography laboratory. Contrast
echocardiographycanalsobeusedforen-
hancement of Doppler signals. This can
be achieved even after fragmentation of
contrast microbubbles, in the absence of
visible opaciﬁcation of the cardiac cav-
ities, owing to remaining microbubble
shells in the circulation. More advanced
use of UCAs includes myocardial con-
trast echocardiography (MCE), which is
technically challenging and requires sig-
niﬁcant experience. The adoption of this
technique, despite several favorable clin-




Fig. 18 aA nondiagnostic four-chamber apical viewobtained from a patientwith severe chronic
obstructive pulmonary disease.b Performing a left ventricular opaciﬁcation study improved the en-
docardial deﬁnition









Coronary blood ﬂow is equally dis-
tributed between the arteries and arte-
rioles, capillary network, and venules.
Myocardial blood volume represents
a third of total coronary ﬂow, of which
more than 90% resides in the capillary
network [22]. MCE relies on the in-
tensity of the backscattered ultrasound
from the ﬁlled capillaries with UCA
and suppression of those reﬂected from
the myocardial tissue. UCAs are pure
intravascular traces and if they are the
only source of the backscattered signals
then the intensity of such signals will be
proportionate to the myocardial blood
volume. Providing the rate ofmyocardial
blood ﬁlling by the contrast microbub-
bles is measurable, then the myocardial
blood ﬂow, which is a product of my-
ocardial blood volume multiplied by
velocity, can be calculated.
There are essentially two main MCE
imaging techniques.
Destructive (high MI) imaging tech-
niques use an MI > 1 that will cause
microbubble destruction, resulting in
a nonlinear response and generation of
strong harmonic signals in multiples of
the transmitted fundamental frequency.
However, after the destruction phase,
the myocardium will require some time
to be reﬁlled with contrast. Therefore,
it is not possible to perform real-time
MCE and imaging should be done by
triggering ultrasound every few frames
(1, 2, 3, and up to10). This means that
assessment of wall motion abnormality
with triggered imaging is not possible,
which is considered an important dis-
advantage. Moreover, it is diﬃcult to
maintain the same imaging window in-
between triggered frames. For these rea-
sons, high-MI MCE is not the preferred
modality in daily practice.
The two main destructive techniques
are harmonic power Doppler and pulse
inversion Doppler. In harmonic power
Doppler, two consecutive pulses are
transmitted in the same scan line. The
reﬂected backscatter from the ﬁrst pulse
will be from both tissue and myocardial
capillaries, while the signals from the sec-
ond pulse will be solely from myocardial
tissue (because of microbubble destruc-
tion by the ﬁrst pulse). If the myocardial
capillaries are not ﬁlled with contrast
because of a perfusion defect, then there
will not be a shift in frequency, whereas
a normally perfused myocardium will
result in backscatter signals from both
tissue and microbubbles from the ﬁrst
pulse and only the tissue from the sec-
ond pulse. In pulse inversion Doppler,
two pulses are sent down shortly after
each other that are 180° out of phase.
Since the response of the myocardial
tissue to the transmitted signal will be
linear, they will cancel each other out.
However, microbubbles will respond in
Herz
Fig. 39 a–c Conﬁrmation
of apical thrombus in the
left ventricle apex in a left
ventricular opaciﬁcation
study showing a ﬁlling de-
fect (yellow arrow)
Fig. 48 Real-time low-MImyocardial contrast echocardiography.a, b Immediately after ﬂash func-
tion;cascontrastappears in themyocardium,yellowarrowsshowalargeareaofperfusiondefect in the
lateralwall in theapical four-chamberview;d red arrows show theperfusiondefect in the inferolateral
wall in the apical three-chamber view.Coronary angiography ﬁndingswere consistentwith a critical
stenosis in the left circumﬂex artery
Fig. 58 Another case of real-time low-MImyocardial contrast echocardiography that demonstrates
amyocardial perfusion defect in an apical two-chamber view.Blue arrow epicardial wall, yellowarrow
subendocardialperfusiondefect, red arrow transmuralperfusiondefect.Coronaryangiogramshowed
signiﬁcant right and left coronary artery disease
a nonlinear fashion and therefore the
backscattered signal intensity will be
a reﬂection of the contrast microbubbles
in the myocardial capillaries. At high
MI, myocardial tissue will also produce
harmonics that will be ﬁltered out using
modern narrow-band transducers.
Nondestructive or real-time low-MI
imaging techniques allow for simultane-
ous assessment of the left ventricular
regional wall motion with perfusion
imaging. This means a minimum frame
rate of 25MHz is required and thus
a lower MI (usually less than 0.2) is used
to avoid microbubble destruction, but
this is at the cost of a weaker backscatter
from the microbubbles. The nonde-
structive techniques are essentially the
same as destructive ones but use a lower
amplitude of transmitted waves. In
power modulation technique (Phillips,
USA), multiple pulses are transmitted
in each scan line with each alternate
phase only in 50% amplitude pulses. The
ultrasound scanner doubles the received
signals from the 50% amplitude pulses
and then subtracts that from the re-
ceived signal from the 100% amplitude
pulses. Therefore, backscattered signals
from the myocardial tissue, which pro-
duces a linear response, will be cancelled
out. Power modulation is considered
a highly sensitive technique but has
lower resolution and image quality [3].
Pulse inversionDoppler, as was explained
in high-MI imaging, can also be used
in the real-time low-MI MCE. In this
technique, essentially, nonlinear scatters
from the microbubbles will be detected
while linear response from myocardial
tissue will be canceled resulting in high-
resolution images. However, because it
can only receive even harmonics, there
will be attenuation artifact, particu-
larly in the basal myocardial segments.
The contrast pulse sequencing (Siemens,
Herz
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Fig. 69 Diagram illustrat-
ing the basic principles of
quantiﬁcation ofmyocar-
dial blood ﬂowby real-time
low-MImyocardial con-
trast echocardiography.
The plateau portion of the
reperfusioncurve ispropor-
tional tomyocardial blood
volume (A). The slope of
the curve is proportional to
blood ﬂow velocity (B). R(t)
is proportional tomyocar-
dial blood ﬂow. (Modiﬁed
fromMonaghan [30])
USA) is another multiphase technique
that uses both alternate amplitude and
polarity resulting in high image qual-
ity and sensitivity but is still subject to
attenuation ([3]; . Figs. 4 and 5).
An important advantage of MCE
compared with other noninvasive imag-
ing modalities is the ability to calculate
myocardial blood ﬂow. This is mea-
sured by multiplying myocardial blood
volume and myocardial contrast ve-
locity and was ﬁrst introduced by Wei
and Kaul in 1998, using high-MI inter-
mittent triggered imaging. When the
ultrasound pulsing interval is incremen-
tally varied, mean microbubble velocity
and peak signal density (representing
myocardial blood volume) and thus my-
ocardial blood ﬂow can be measured
[23]. Use of the ﬂash option, in real-
time low-MI imaging, destroys the UCA
in myocardium (while microbubbles re-
main intact in the left ventricle owing
to a higher concentration) and allows
for measurement of contrast replenish-
ment velocity and thus quantiﬁcation of
myocardial blood ﬂow (. Fig. 6).
A prerequisite for MCE is that the re-
lationship between the contrast concen-
tration and the scatter intensity is linear.
With a contrast bolus injection, at a cer-
tain level, when themaximumUCA con-
centration is achieved, the linear relation-
ship is lost. At this point, even a hypoper-
fused region may appear falsely normal.
It isonlyduringthecontrastdecaythatthe
myocardial contrast intensity and hence
the myocardial blood volume can be as-
sessed. Thus, with the bolus injection,
maintaining a window where the UCA
can be detected and yet not saturated is
crucial. Whereas with the contrast in-
fusion, an optimal level of microbubble
concentration within the myocardium
can be easily achieved. Moreover, since
the mean transit time of the microbub-
bles during contrast injection cannot be
calculated, it is impossible to measure
myocardial blood ﬂow. For these rea-
sons a contrast infusion is preferred for
performing MCE.
Stress MCE
Exercise, vasodilators, or inotropes can
be used for stress MCE. The incorpo-
ration of MCE into an exercise stress
test is challenging but has been shown
to be feasible with improvement of
both left ventricular wall assessment
and perfusion [23, 24]. It is known
that a perfusion defect precedes a wall
motion abnormality in the ischemic cas-
cade. MCE has the ability to detect such
perfusion defects during dobutamine
stress echocardiography. Dolan et al.
demonstrated that the presence of a per-
fusion defect during dobutamine stress
echocardiography, even in the absence
of any wall motion abnormality, is an
independent prognostic factor for death
and nonfatal myocardial infarction [25].
Stress MCE has been studied against
the gold standard of coronary angiogra-
phy in 20 trials with diﬀerent protocols
involving 1683 patients, demonstrating
sensitivity and speciﬁcity of 83% and
80%, respectively [26]. A meta-analy-
sis investigating the accuracy of stress
MCE, single-photon emission computed
tomography (SPECT), and dobutamine
stress echocardiography against coro-
nary angiography as gold standard also
showed a higher sensitivity in favor of
stress MCE [27]. Despite several favor-
able studies, in a more recent European
multicenter study using coronary an-
giography as a gold standard, although
stress MCE yielded better sensitivity
(75%) in detecting coronary stenosis of
>70% against SPECT, it was signiﬁcantly
inferior in speciﬁcity (52%).
MCE for myocardial viability
MCE can be used for the assessment of
myocardial tissue viability since an intact
tissue will be replenished with contrast
because the capillaries and microvascu-
lature will still be intact, whereas an is-
chemic or fully infarcted territory will
show patchy or absent contrast density.
In fact, the contrast density has an in-
verse relationship with myocardial colla-
Herz
gen. MCE has been used for evaluation
of the myocardial viability in both acute
and chronic settings. Ito in 1992 demon-
strated that despite a patent artery related
to an infarcted zone, up to25%ofpatients
did not showmyocardial opaciﬁcation in
an infarcted area and thus nomyocardial
viability, a phenomenon that is called “no
ﬂow” andwas ﬁrst described byKolner in
1974. Other studies have shown the inde-
pendent prognostic impact of assessment
of the infarct-related myocardial region
(treated with either thrombolysis or per-
cutaneous intervention) on left ventricu-
lar remodeling and death [23]. Perfusion
imaging with MCE has also been stud-
ied in nonacute coronary artery disease.
Quantiﬁcation of myocardial blood ﬂow
with MCE has been shown to improve
accuracy in detecting viablemyocardium
when compared with both dobutamine
stress echocardiography and SPECT in
those with left ventricular dysfunction
and coronary artery disease [28]. The
overall sensitivity and speciﬁcity of per-
fusion imaging with MCE have been re-
ported as 85% and 70%, respectively [6].
MCE in suspected acute coronary
syndrome
A study by Gaibazzi et al. showed that
a positive stress MCE predicted a 1-year
incidence of acute coronary syndrome in
thosewhopresentedtotheemergencyde-
partment with chest pain and unremark-
able ECG changes and negative troponin
ﬁndings. This suggests a possible role for
bedside stress MCE in risk stratiﬁcation
of these patients [29].
Safety
Despite the initial concern about the
safety of UCAs, there is a universal con-
sensus that contrast echocardiography is
safe. Although extremely rare, anaphy-
lactic reaction remains a true side eﬀect
that has been reported in approximately
1 in 10,000 patients. Use of UCAs in
pulmonary hypertension, right-to-left
shunt through a patent foramen ovale,
and in critically ill patients that were
of initial concern have been proved in
several studies to be safe [3].
Conclusion
Contrast echocardiography should be
an integral part of a modern echocar-
diography laboratory and is consid-
ered as a quality control marker. LVO
has an established role in a wide range
of clinical scenarios in rest echocar-
diography and improves the accuracy
of stress echocardiography. Perfusion
imagingwith MCE, although supported
by a large body of evidence, has not
passed the regulatory processes in the
EU and USA and thus remains an oﬀ-
label indication and currently limited
to expert centers. Beyond daily clinical
use, UCAs are currently being tested
in trials for molecular imaging and tar-
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